Solving the PCT Priority problem
USPTO temporarily allows online plant patent filings
Self-collision of European patent filings: an accident waiting to happen?
Mongkolchon Akesin / Shutterstock.com
Patents are a key asset for pharmaceutical startups, but where are they choosing to file? Jian Siang Poh and Angus Fairbairn of Marks & Clerk report.
The development of any new drug requires considerable investment of time and resources into extensive research and development (R&D), even in the hit to lead and pre-clinical stages. While larger pharmaceutical companies with deep pockets are used to managing the costs associated with drug development, pharmaceutical startups and small and medium-sized enterprises (SMEs) may encounter more difficulty in balancing their budgets, particularly when it comes to allocating funds for generating patent portfolios.
In this article, we provide an insight into the patent filing trends of pharmaceutical startups and SMEs, in terms of the jurisdictions that are prioritised when seeking patent protection.
Patents play a crucial role in establishing rights that pharmaceutical startups and SMEs need to reap the reward of their R&D and to secure further investment. As a result, patent protection is typically considered and applied for at a very early stage in the drug development process.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at email@example.com.
If you have any technical issues please email tech support.
Patent filing, pharmaceutical startups, Marks & Clerk, R&D, SMEs, portfolio, Patent Cooperation Treaty, G20, PCT applications